Figure 2 | Scientific Reports

Figure 2

From: Bayesian analysis of cytokines and chemokine identifies immune pathways of HBsAg loss during chronic hepatitis B treatment

Figure 2

Cytokines that are different between responders and non-responders at the time-points tested. (A) Cytokines, chemokines and soluble factors that are significantly increased (blue) or decreased (red) in treatment responders is shown. Statistical analysis was done using t-test. *Indicates P value < 0.05 (BD) Modular analysis of cytokines and chemokines between responders and non-responders. Bar graphs representing the cytokines and chemokines of (B) Type 1 pathway, (C) Type 2 pathway, and (D) Type 17 pathway at the time-point before loss of HBsAg are shown. *Indicates P value < 0.05 from t-test with multiple test corrections.

Back to article page